MONDRAGON Health takes part in AseBio Investor Day


A new edition of AseBio Investor Day took place yesterday at the Kursaal (Donostia, Gipuzkoa), the main biotechnology investment forum in Spain. The aim of this event is to bring together biotech companies and innovative projects in search of funding.

It was attended by both local and international investors, as well as companies in the biotechnology field and research institutions. The Managing Director of MONDRAGON Health, Hector Olabegogeaskoetxea, took part in the round table on the positioning Gipuzkoa as a destination of choice for investment in manufacturing of advanced therapies. The round table was moderated by Ainhoa Aizpuru, Project Manager at BIC Gipuzkoa Berrilan and was made up of Ane Insausti, Deputy for Economic Promotion and Strategic Projects, Provincial Council of Gipuzkoa; Javier García Cogorro, General Partner, Columbus Venture Partners; Jimmy Vanhove, CEO of Viralgen; and Guillermo Arregui, Founder and CEO of Radar Ventures, talked about how to turn Gipuzkoa into a privileged destination in the field of investment in Biosciences.

Hector Olabegogeaskoetxea, highlighted the contribution that MONDRAGON can make through industrial support or Contract Manufacturing. This type of support involves the presentation of specific challenges in the industrial field, such as certifications and knowledge in the supply chain and production. With its extensive experience and resources, MONDRAGON is positioned as a strategic ally to support and accompany start-ups in the face of the different obstacles and challenges they may face, trying to reach their maximum potential.

He also encouraged those attending to contact MONDRAGON Health to discuss their current projects, explore the challenges they may face and assess how MONDRAGON can offer them support. As part of the corporate strategy of activating entrepreneurial skills and promoting new businesses among the co-operatives, with a commitment to young companies with the capacity for growth, MONDRAGON, through its corporate Promotion Centre, has for the last five years been investing in around twenty start-ups, involving the co-operatives in their capital and supporting them when necessary with Corporate Venture Capital Funds. “It is important to offer financial support adapted to the needs of the start-ups, recognising the uniqueness of each one and the challenges they may face”, Olabegogeaskoetxea pointed out.